IL4 and pulmonary arterial hypertension: The P90 nanoparticles decreased the protein level of IL-13, P90-BaP reduced the protein level of IL-4, P90-9NA induced the decrease of IL-1β and IL-13, and AS-PAH decreased the protein levels of IL-4 and IL-1β.